SCHEMBL7612960

SCHEMBL7612960

Cc1nc2cccc(OCc3c(C)cccc3C)c2[nH]1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SGMS2 Q8NHU3 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RAB9A P51151 5/20 0.46
NPC1 O15118 4/20 0.46
PARP1 P09874 1/20 0.42
SLC22A12 Q96S37 4/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
CRHBP P24387 1/20 0.37
CRHR2 Q13324 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
AR P10275 1/20 0.36
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7620069 0.88 SMN1; SMN2 (0.40) SGMS2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL7619113 0.82 L3MBTL1 (0.54) RAB9ANPC1SMN1; SMN2LMNAMAPT
SCHEMBL9528492 0.80 MAPT (0.54) RAB9ANPC1SMN1; SMN2ALDH1A1PKM
SCHEMBL9528423 0.79 MAPT (0.53) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL7612954 0.77 DRD2 (0.53) SGMS2CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4611131 0.76 ALDH1A1 (0.46) RAB9ANPC1PARP1SMN1; SMN2ALDH1A1
SCHEMBL31033488 0.75 PARP1 (0.56) RAB9ANPC1PARP1SMN1; SMN2ALDH1A1
SCHEMBL353892 0.75 PARP1 (0.56) RAB9ANPC1PARP1SMN1; SMN2ALDH1A1
SCHEMBL9529218 0.74 DRD2 (0.45) PARP1KMT2AARMAPT
Bromide SCHEMBL5318093 0.73 PARP1 (0.55) RAB9ANPC1PARP1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906288-B1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2002-11-06 EP claimed
US-6465505-B1 SUCH AS 4-(2,6-DIMETHYLBENZYLAMINO OR BENZYLOXY)-2-METHYL BENZIMIDAZOLE; INHIBITING EXOGENOUS OR ENDOGENOUS STIMULATED GASTRIC ACID SECRETION; PREVENTION AND TREATMENT OF GASTRO-INTESTINAL INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2002-10-15 US claimed
EP-0906288-A1 NEW COMPOUNDS Astra Aktiebolag (SE) 1999-04-07 EP claimed
WO-1997047603-A1 NEW COMPOUNDS ASTRA AKTIEBOLAG (SE) 1997-12-18 WO claimed
EP-0906288-B1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2002-11-06 EP disclosed
US-6465505-B1 SUCH AS 4-(2,6-DIMETHYLBENZYLAMINO OR BENZYLOXY)-2-METHYL BENZIMIDAZOLE; INHIBITING EXOGENOUS OR ENDOGENOUS STIMULATED GASTRIC ACID SECRETION; PREVENTION AND TREATMENT OF GASTRO-INTESTINAL INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2002-10-15 US disclosed
EP-0906288-A1 NEW COMPOUNDS Astra Aktiebolag (SE) 1999-04-07 EP disclosed
WO-1997047603-A1 NEW COMPOUNDS ASTRA AKTIEBOLAG (SE) 1997-12-18 WO disclosed